KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Chemed (CHE) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $428.0 million.

  • Chemed's Cost of Revenue rose 802.8% to $428.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 1105.61%. This contributed to the annual value of $1.6 billion for FY2024, which is 759.67% up from last year.
  • Latest data reveals that Chemed reported Cost of Revenue of $428.0 million as of Q3 2025, which was up 802.8% from $434.1 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Cost of Revenue registered a high of $434.1 million during Q2 2025, and its lowest value of $336.3 million during Q4 2021.
  • Its 5-year average for Cost of Revenue is $372.3 million, with a median of $362.4 million in 2023.
  • Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 390.08% in 2022, then soared by 1326.34% in 2024.
  • Quarter analysis of 5 years shows Chemed's Cost of Revenue stood at $336.3 million in 2021, then grew by 3.94% to $349.6 million in 2022, then increased by 2.51% to $358.3 million in 2023, then increased by 13.26% to $405.9 million in 2024, then increased by 5.45% to $428.0 million in 2025.
  • Its Cost of Revenue was $428.0 million in Q3 2025, compared to $434.1 million in Q2 2025 and $430.5 million in Q1 2025.